| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +80.00% | -0.74% | +0.25% | -0.99% | -2.10% | — |
| 14d | 5 | +80.00% | -4.75% | +0.56% | -5.31% | -13.23% | — |
| 30d | 5 | +80.00% | +0.44% | +1.09% | -0.65% | -2.40% | — |
| 60d | 5 | +60.00% | -4.73% | +4.75% | -9.48% | +1.52% | — |
| 90d | 5 | +100.00% | -10.47% | +3.96% | -14.43% | -13.05% | — |
| 180d | 5 | +100.00% | -19.10% | +5.98% | -25.08% | -29.11% | — |
| 1y | 5(1 pending) | +75.00% | -27.64% | +17.88% | -45.52% | -45.17% | — |
| 2y | 5(4 pending) | +100.00% | +140.56% | +55.98% | +84.58% | +84.58% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| DRMA DERMATA THERAPEUTICS, INC. | SALE | 11 | $1.19 | $13 | 0 | Jun 16, 2026 | Jun 16, 2026 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 240,000 | — | — | 240,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,500 | — | — | 2,500 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,500 | $15.00 | $187.5K | 10,042 | Aug 21, 2025 | Aug 22, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 12,500 | $1.50 | $18.8K | 22,542 | Aug 21, 2025 | Aug 22, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 12,500 | — | — | 739,830 | Aug 21, 2025 | Aug 22, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 50,000 | $1.50 | $75.0K | 57,424 | May 20, 2025 | May 22, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 50,000 | — | — | 752,330 | May 20, 2025 | May 22, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 50,000 | $14.10 | $705.2K | 7,424 | May 20, 2025 | May 22, 2025 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | — | — | 5,000 | Jan 13, 2025 | Jan 14, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 176,700 | — | — | 176,700 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 12,500 | — | — | 802,330 | Oct 16, 2024 | Oct 17, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 12,500 | $1.50 | $18.8K | 17,449 | Oct 16, 2024 | Oct 17, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,500 | $16.00 | $200.0K | 4,949 | Oct 16, 2024 | Oct 17, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 12,500 | $1.50 | $18.8K | 25,699 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 12,500 | — | — | 814,830 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,500 | $16.00 | $200.0K | 13,199 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 10,000 | — | — | 10,000 | Jan 4, 2024 | Jan 5, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Jan 3, 2023 | Jan 5, 2023 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 8,250 | $6.24 | $51.5K | 8,250 | Nov 29, 2022 | Dec 1, 2022 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 827,330 | — | — | 827,330 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 11,359 | — | — | 27,145 | Oct 6, 2022 | Oct 7, 2022 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,960 | — | — | 15,786 | Jul 7, 2022 | Jul 8, 2022 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,826 | — | — | 5,826 | Apr 7, 2022 | Apr 8, 2022 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | — | — | 5,000 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 10,000 | — | — | 10,000 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |